Literature DB >> 3564840

Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease.

F Laczi, T Janáky, T Iványi, J Julesz, F A László.   

Abstract

The osmoregulation of arginine-8-vasopressin (AVP) was investigated in 14 patients with primary hypothyroidism and in 6 with Addison's disease. Plasma AVP was measured by radioimmunoassay. Patients with primary hypothyroidism were classified into subgroups with elevated (6.81 +/- 1.12 pmol/l) or normal (3.92 +/- 0.96 pmol/l) basal levels of plasma AVP. Following the infusion of 2.5% saline, a positive correlation was established between plasma AVP and plasma osmolality. A decreased osmotic threshold was found in hypothyroid patients with augmented basal AVP levels (pAVP = 0.37 (pOs-265), r = 0.71, P less than 0.01) as compared with that in hypothyroid patients with a normal AVP level (pAVP = 0.42 (pOs-280), r = 0.93, P less than 0.001). A relationship was demonstrated between the alteration in the AVP osmoregulation and the severity of the thyroid insufficiency. Patients with Addison's disease exhibited an increased basal level of plasma AVP (9.59 +/- 1.25 pmol/l) and a decreased osmotic threshold (pAVP = 0.42 (pOs-261), r = 0.63, P less than 0.01) contrasted to that of healthy volunteers (pAVP = 0.41 (pOs-280), r = 0.83, P less than 0.001). The osmoregulation disturbance of the AVP secretion may play a major role in the impaired water metabolism in primary hypothyroidism and in Addison's disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3564840     DOI: 10.1530/acta.0.1140389

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  A rare case of fatal hyponatremia due to a combination of psychotropic polypharmacy and hypothyroidism.

Authors:  Chaitanya K Musham; Archana Jarathi; Gabriel Pedraza
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Diagnosis and treatment of ACTH deficiency.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

3.  Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.

Authors:  S J Holmes; C M Florkowski; M J Evans; M J Ellis; J H Livesey; R A Donald; E A Espiner
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

4.  Severe hyponatremia and repeated intestinal resections for intestinal dysmotility mimicking congenital aganglionic megacolon due to delay in the diagnosis of congenital hypothyroidism.

Authors:  Gonul Buyukyilmaz; Demet Baltu; Tutku Soyer; Murat Tanyıldız; Huseyin Demirbilek
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.